V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180006130 | 180002275 | null | null | null | null | 2020-07-10 | CARBOPLATIN + GEMCITABINE + RITUXIMAB | null | null | GEMCITABINE | 100781987 |
| 180006158 | 180002277 | null | null | null | null | 2018-04-22 | FCarboSt | null | null | NB HRNBL-1 ISOTRETINOIN | 100651858 |
| 180006164 | 180002278 | null | null | null | null | 2017-11-27 | Ipilimumab | null | null | LENVATINIB | 100939205 |
| 180006214 | 180002281 | null | null | null | 2017-08-08 | 2018-06-16 | BUSULFAN + MELPHALAN | null | null | LENVATINIB | 100116896 |
| 180006303 | 180002285 | null | null | null | null | 2017-08-07 | Doxorubicin 75mg/m2 | null | null | SORAFENIB | 100648840 |
| 180006482 | 180002293 | null | null | null | null | 2020-04-14 | NB HRNBL-1 BUMEL MAT | null | null | NB HRNBL-1 ISOTRETINOIN | 101450779 |
| 180006571 | 180002300 | null | null | null | null | 2018-08-22 | IBRUTINIB | null | null | NB HRNBL-1 COJEC IND COURSE C | 101626114 |
| 180006580 | 180002301 | null | null | null | null | 2017-07-30 | NB 13 cis-RA (Isotretinoin) | null | null | NB HRNBL-1 ISOTRETINOIN | 100809680 |
| 180006582 | 180002302 | null | null | null | null | 2019-07-17 | Capecitabine + Oxaliplatin 21day | null | null | NB RELAPSE TEMOZOLOMIDE/ TOPOTECAN | 101038255 |
| 180006801 | 180002316 | null | null | null | 2019-07-13 | 2019-07-25 | LENVATINIB | null | null | CISPLATIN + GEMCITABINE | 101475957 |
| 180006830 | 180002317 | null | null | null | null | 2017-10-08 | CNS GCT II Germinoma - Ifos Etop | null | null | PEMBROLIZUMAB | 101821960 |
| 180006912 | 180002319 | 1.38 | null | null | 2017-03-04 | 2020-04-07 | Mitotane 3 - 3.5g | null | null | TRASTUZUMAB | 101745337 |
| 180007207 | 180002339 | null | null | null | null | 2019-12-25 | null | null | null | CISPLATIN | 100314802 |
| 180007244 | 180002343 | null | null | null | 2017-01-16 | 2017-10-11 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 100431921 |
| 180007273 | 180002344 | null | null | null | 2017-12-07 | 2018-03-15 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | null | null | CARBOPLATIN + PACLITAXEL | 100541864 |
| 180007308 | 180002345 | null | null | null | null | 2018-07-14 | NB Rel CCLG guidelines Cyclo-Topotecan | null | null | LENVATINIB | 101258134 |
| 180007477 | 180002352 | null | null | null | null | 2021-12-27 | CABOZANTINIB | null | null | LENVATINIB | 101292178 |
| 180007527 | 180002354 | null | null | null | null | 2021-10-30 | LENVATINIB | N | null | CABOZANTINIB | 100606459 |
| 180007534 | 180002355 | 1.71 | null | null | null | 2021-05-07 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | SORAFENIB | 101313030 |
| 180007787 | 180002362 | null | null | null | null | 2019-01-10 | Cisplatin+Doxorubicin+Etoposide 28d | null | null | ALL UKALL2011 IND A | 101619620 |
| 180007817 | 180002363 | null | null | null | null | 2018-03-08 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 101471380 |
| 180007865 | 180002364 | null | null | null | 2019-08-05 | 2019-08-15 | NB Rel CCLG guidelines Cyclo-Topotecan | null | null | LENVATINIB | 101652260 |
| 180007867 | 180002365 | null | null | null | null | 2019-07-01 | Trial Unspecified | null | null | NB HRNBL-1 ISOTRETINOIN | 101807444 |
| 180007931 | 180002367 | null | null | null | 2017-08-17 | 2017-08-30 | Cyclophosphamide High Dose | null | null | NB HRNBL-1 ISOTRETINOIN | 100773632 |
| 180007971 | 180002368 | null | null | null | null | 2019-04-06 | Trial Unspecified | null | null | NB HRNBL-1 ISOTRETINOIN | 101590985 |
| 180007984 | 180002370 | null | null | null | null | 2018-11-05 | null | null | null | VENETOCLAX | 101593381 |
| 180008036 | 180002372 | null | null | null | 2017-09-30 | 2017-10-11 | LENVATINIB | null | null | ALL UKALL2011 IND A | 100074558 |
| 180008041 | 180002373 | null | null | null | null | 2021-11-11 | NB BEACON Temozolomide alone | null | null | ETOPOSIDE | 100156298 |
| 180008148 | 180002378 | null | null | null | 2020-06-20 | 2021-03-24 | Antibody NBL | null | null | LENVATINIB | 100710093 |
| 180008150 | 180002379 | null | null | null | null | 2020-10-01 | NB HRNBL-1 Isotretinoin | null | null | CARBOPLATIN + PACLITAXEL | 101390934 |
| 180008213 | 180002382 | 1.75 | null | null | null | 2016-11-25 | NB HRNBL-1 BUMEL MAT | null | null | SELPERCATINIB | 100905922 |
| 180008266 | 180002385 | null | null | null | null | 2016-04-13 | Paclitaxel 7 day | null | null | SORAFENIB | 100835399 |
| 180008397 | 180002396 | null | null | null | null | 2016-09-12 | Carboplatin + Paclitaxel (3 weekly) | null | null | GEMCARBO | 100905689 |
| 180008632 | 180002414 | null | null | null | 2021-09-26 | 2021-10-10 | CABOZANTINIB | null | null | NB HRNBL-1 ISOTRETINOIN | 100165517 |
| 180008645 | 180002415 | null | null | null | null | 2019-08-10 | ATEZOLIZUMAB + NAB PACLITAXEL | null | null | LENVATINIB | 100416811 |
| 180008691 | 180002419 | null | null | null | null | 2021-08-25 | Vinorelbine (oral) | null | null | PACLITAXEL | 100282974 |
| 180008694 | 180002420 | null | null | null | null | 2019-01-02 | NB HRNBL-1 Isotretinoin | null | null | LENVATINIB | 101118840 |
| 180008714 | 180002422 | null | null | null | 2016-07-25 | 2017-12-12 | NB 13 cis-RA (Isotretinoin) | null | null | LENVATINIB | 101113304 |
| 180008722 | 180002423 | null | null | null | null | 2016-05-21 | NB HRNBL-1 Isotretinoin | null | null | DINUTUXIMAB BETA | 101323603 |
| 180008737 | 180002424 | null | null | null | null | 2022-02-02 | null | null | null | TRIAL UNSPECIFIED | 100597873 |
| 180008824 | 180002429 | null | null | null | null | 2016-09-27 | NB HRNBL-1 BUMEL MAT | null | null | LENVATINIB | 100891060 |
| 180008856 | 180002432 | null | null | null | 2016-04-18 | 2016-05-17 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101810237 |
| 180008892 | 180002434 | null | null | null | null | 2018-09-21 | null | null | null | LENVATINIB | 100126379 |
| 180008916 | 180002438 | null | null | null | null | 2020-12-06 | NB HRNBL-1 COJEC Ind COURSE A | null | null | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE | 100770424 |
| 180008988 | 180002444 | null | null | null | null | 2017-12-11 | NB Rel CCLG guidelines Cyclo-Topotecan | null | null | NB HRNBL-1 ISOTRETINOIN | 101397408 |
| 180009019 | 180002446 | null | null | null | 2019-06-16 | 2019-06-17 | Trial Unspecified | null | null | CARBOPLATIN | 101120145 |
| 180009050 | 180002449 | null | null | null | null | 2019-01-31 | Trial Unspecified | null | null | NB HRNBL-1 ISOTRETINOIN | 100336865 |
| 180009097 | 180002453 | null | null | null | null | 2017-09-13 | CABOZANTINIB | null | null | CABOZANTINIB | 100944191 |
| 180009122 | 180002455 | null | null | null | null | 2018-10-29 | NB HRNBL-1 BUMEL MAT | null | null | LENVATINIB | 100159119 |
| 180009166 | 180002458 | null | null | null | 2020-10-31 | 2020-11-01 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 100508697 |